|
1
|
Santos AA, Lopes CC, Ribeiro JR, Martins
LR, Santos JC, Amorim IF, et al: Identification of prognostic
factors in canine mammary malignant tumours: a multivariable
survival study. BMC Vet Res. 9:12013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Karayannopoulou M, Kaldrymidou E,
Constantinidis TC and Dessiris A: Adjuvant post-operative
chemotherapy in bitches with mammary cancer. J Vet Med A Physiol
Pathol Clin Med. 48:85–96. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Muhammadnejad A, Keyhani E, Mortazavi P,
Behjati F and Haghdoost IS: Overexpression of HER-2/neu in
malignant mammary tumors; translation of clinicopathological
features from dog to human. Asian Pac J Cancer Prev. 13:6415–6421.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Queiroga FL, Raposo T, Caravalho MI, Prada
J and Pires I: Canine mammary tumours as a model to study human
breast cancer: most recent findings. In Vivo. 25:455–465.
2011.PubMed/NCBI
|
|
5
|
Karihtala P, Auvinen P, Kauppila S,
Haapasaari KM, Jukkola-Vuorinen A and Soini Y: Vimentin, zeb1 and
Sip1 are up-regulated in triple-negative and basal-like breast
cancers: association with an aggressive tumour phenotype. Breast
Cancer Res Treat. 138:81–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Pinho SS, Carvalho S, Cabral J, Reis CA
and Gärtner F: Canine tumors: a spontaneous animal model of human
carcinogenesis. Transl Res. 159:165–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yamashita N, Tokunaga E, Kitao H,
Hisamatsu Y, Taketani K, Akiyoshi S, et al: Vimentin as a poor
prognostic factor for triple-negative breast cancer. J Cancer Res
Clin Oncol. 139:739–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kokkinos MI, Wafai R, Wong MK, Newgreen
DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal
transition in human breast cancer - observations in vitro and in
vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cassali GD, Lavalle GE, De Nardi AB,
Ferreira E, Bertagnolli AC, Estrela-Lima A, et al: Consensus for
the diagnosis, prognosis and treatment of canine mammary tumors.
Braz J Vet Pathol. 4:153–180. 2011.
|
|
10
|
Goldschmidt M, Pena L, Rasotto R and
Zappulli V: Classification and grading of canine mammary tumors.
Vet Pathol. 48:117–131. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hemalatha A, Suresh TN and Kumar ML:
Expression of vimentin in breast carcinoma, its correlation with
Ki67 and other histopathological parameters. Indian J Cancer.
50:189–194. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dhakal HP, Bassarova A, Naume B,
Synnestvedt M, Borgen E, Kaaresen R, et al: Breast carcinoma
vascularity: a comparison of manual microvessel count and Chalkley
count. Histol Histopathol. 24:1049–1059. 2009.PubMed/NCBI
|
|
13
|
da Silva BB, Lopes-Costa PV, dos Santos
AR, de Sousa-Júnior EC, Alencar AP, Pires CG, et al: Comparison of
three vascular endothelial markers in the evaluation of microvessel
density in breast cancer. Eur J Gynaecol Oncol. 30:285–288.
2009.PubMed/NCBI
|
|
14
|
Vora HH, Patel NA, Rajvik KN, Mehta SV,
Brahmbhatt BV, Shah MJ, et al: Cytokeratin and vimentin expression
in breast cancer. Int J Biol Markers. 24:38–46. 2009.PubMed/NCBI
|
|
15
|
Moustakas A and Heldin P: TGFβ and
matrix-regulated epithelial to mesenchymal transition. Biochim
Biophys Acta. Feb 18–2014.(Epub ahead of print).
|
|
16
|
Yoshida K, Saito T, Kamida A, Matsumoto K,
Saeki K, Mochizuki M, et al: Transforming growth factor-β
transiently induces vimentin expression and invasive capacity in a
canine mammary gland tumor cell line. Res Vet Sci. 94:539–541.
2013.
|
|
17
|
Satelli A and Li S: Vimentin in cancer and
its potential as a molecular target for cancer therapy. Cell Mol
Life Sci. 68:3033–3046. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Król M, Pawłowski KM, Szyszko K,
Maciejewski H, Dolka I, Manuali E, Jank M and Motyl T: The gene
expression profiles of canine mammary cancer cells grown with
carcinoma-associated fibroblasts (CAFs) as a co-culture in vitro.
BMC Vet Res. 8:352012.PubMed/NCBI
|
|
19
|
Terra EM, Magalhães GM, Rodrigues MP,
Amorim RL, Rocha NS and Costa MT: Immunohistochemical expression of
TGFβ, E-cadherin and vimentin in benign and malignant neoplasias of
canine mammary gland. BMC Proceedings. 7(Suppl 2): P202013.
|
